LOG IN

Members and suppliers: Join our online community

Access our full library of resources, register for events and webinars and share audits and other assessments

News

Sort By
This event was published on 27 June
PSCI Decarbonization Summit for Pharma & Healthcare Suppliers

PSCI Decarbonization Summit for Pharma & Healthcare Suppliers

Conference | 22–23 Oct 2025

Save the date for the first-ever PSCI summit for suppliers focused on the critical topic of decarbonization

The pharma industry represents 5% of worldwide emissions and we know that achieving net zero requires collaboration between all parties in the value chain. To enable both practical and efficient collaboration between PSCI member companies and suppliers, we will be hosting a dedicated summit to:

  • clearly communicate PSCI member requirements
  • build capability
  • and demonstrate an achievable roadmap for the industry to turn decarbonization planning into impact by 2030

More details and an agenda will be available soon.

The summit will take place virtually.

Type
Conference
Date
22–23 Oct 2025
Language
English
This bulletin was published on 26 June
PSCI Members Named on World's Most Sustainable Companies List 2025

PSCI Members Named on World's Most Sustainable Companies List 2025

Congratulations to the PSCI members named in TIME's 500 most sustainable companies list 2025

Over a dozen pharma & healthcare companies, many of which are PSCI members, have been recognized as the world's most sustainable companies 2025. To track how top global firms across industries are rising to sustainability challenges, TIME and data firm Statista partnered to rank the world’s 500 most sustainable companies based on their public commitment to and progress toward sustainability targets during the calendar year of 2023 (the most recent year for which complete data are available).

Special congratulations to Schneider Electric which was ranked number 1 and gained recognition for the Energize program, a supply chain renewables initiative which is endorsed by the PSCI.

You can see the full list of companies here.

This bulletin was published on 19 June
PSCI Endorses Converge Supplier Initiative to Cut Scope 3 Emissions in Pharma

PSCI Endorses Converge Supplier Initiative to Cut Scope 3 Emissions in Pharma

The PSCI has endorsed My Green Lab's Converge Supplier Initiative, a unique industry collaboration designed to support pharmaceutical suppliers in achieving My Green Lab® Certification.

The Converge Supplier Initiative is a unique industry collaboration designed to support pharmaceutical suppliers—including Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), and Contract Development & Manufacturing Organizations (CDMOs)—in achieving My Green Lab® Certification. This certification framework enables suppliers to reduce environmental impact, cut energy and water use, lower costs, and align lab operations with corporate sustainability goals. This endorsement from the PSCI underscores growing momentum across the pharmaceutical industry to reduce supply chain (Scope 3) emissions and foster more sustainable lab operations.

Leading pharmaceutical companies, including AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, GSK, MilliporeSigma, Takeda, and UCB, have not only walked the talk by implementing My Green Lab Certification in their own labs to drive down emissions, but also have joined forces to educate and empower their outsourced research partners through the Converge Supplier Initiative. To date, over 147 supplier organizations have joined the initiative, with 32 already completing pilot certifications.

“The research supply chain represents a significant portion of the pharmaceutical industry’s environmental footprint,” said James Connelly, CEO of My Green Lab. “This endorsement by PSCI reinforces the power of collaborative action and positions the Converge Supplier Initiative as a proven, scalable solution for driving impact reduction on the ground in the labs across the industry.”

PSCI unites pharmaceutical and healthcare companies to advance responsible supply chain practices and drive improved safety, environmental, and social outcomes across the global value chain. Together, PSCI and My Green Lab are aligned in their vision for a more sustainable and collaborative future in science.

“Bristol Myers Squibb is excited to see two important relationships come together with PSCI and Converge. With Converge providing a hands-on, practical approach for suppliers with lab operations to address their footprint through My Green Lab Certification, it dovetails well with PSCI’s drive to see the adoption of sustainable practices in pharmaceutical supply chains. This partnership can accelerate the critical need for pharmaceutical supply chains to reduce their footprint while continuing their missions of delivering for patients,” said Devin Carsdale, Associate Director of Sustainability at Bristol Myers Squibb and PSCI Decarbonization Team Co-Lead.

"We proudly operate 17 labs globally, all of which have achieved My Green Lab Certification," said Bill Sterling, Senior Director of Global Environmental Health and Safety, IQVIA Laboratories. "The My Green Lab program has been instrumental in fostering a culture of sustainability and engaging employees at all sites. It helps support our mission to accelerate innovation for a healthier world and features prominently in our annual sustainability report.”

PSCI’s endorsement also supports the broader United Nations-backed Race to Zero campaign, which calls for 95% of participating organizations’ laboratories globally to achieve My Green Lab Certification at the highest 'Green' Level by 2030, a critical milestone in the path of net-zero emissions in science.

Learn more about My Green Lab Certification here.

This event was published on 16 June
UPDATED: Technical Workshop for Indian-based Suppliers: Process Safety & Industrial Hygiene

UPDATED: Technical Workshop for Indian-based Suppliers: Process Safety & Industrial Hygiene

Conference | 16 Jul 2025 09:00–18:00 Kolkata

Please note the updated topic focus for this workshop is now Process Safety and Industrial Hygiene.

If you have registered for the workshop and are no longer interested or able to attend, please contact us to cancel your registration.

The workshop will focus on the topics of Process Safety and Industrial Hygiene, which have been selected considering the needs of the regional pharma industry in India.

The session is aimed at EHS, Safety and Engineering professionals from Pharma manufacturing industries. There is no registration fee for participating in this event.

Please note that registration for this workshop is limited to 50 participants and the event will take place in-person. No virtual option is available.

We are pleased to be joined by speakers from M/S GVS Cibatech and M/S RECOH EHS who will deliver these sessions.

Agenda

  • 09:00-09:30: Registration & Breakfast
  • 09:30-10:15: Opening including PSCI Introduction
  • 10:15-11:30: Technical Session – 1 (Chemical Reaction hazards – M/s GVS Cibatech)
  • 11:30-11:45: 1st Tea / Coffee break
  • 11:45-13:15: Technical Session – 2 (Chemical Reaction Risk Assessment & Controls – M/S GVS Cibatech)
  • 13:15-14:15: Lunch
  • 14:15-15:30: Technical Session – 3 (Industrial Hygiene Risk Assessment – M/S RECOH EHS)
  • 15:30-15:45: 2nd Tea / Coffee break (Hi-Tea)
  • 15:45-17:30: Technical Session – 4 (Industrial Hygiene Risk Assessment & Controls– M/s RECOH EHS)
  • 17:30-18:00: Vote of thanks
Type
Conference
Date
16 Jul 2025 09:00–18:00 Kolkata
Language
English
Registration for this event is now full
This event was published on 13 June
PSCI Webinar: Strategies for Accurate API Exposure Monitoring

PSCI Webinar: Strategies for Accurate API Exposure Monitoring

Webinar | 5 Aug 2025 14:00–15:00 Amsterdam

Webinar Description:
Over 50% of API and surrogate exposure monitoring results are considered unreliable. Accurate, reproducible, and representative monitoring and analysis of API exposures are essential for protecting worker health and developing effective exposure control strategies. Inaccurate results can lead to significant risks for occupational health and undermine the effectiveness of safety measures.

This webinar will offer practical guidance on sampling strategies and methods to support accurate API exposure assessment, in alignment with PSCI’s principles on health and safety. Drawing on insights from over 5,000 API and surrogate exposure monitoring results, the session will help participants strengthen their industrial hygiene programs with evidence-based best practices and real-world lessons learned.

Speakers:

  • Maharshi Mehta, CIH, CSP, FAIHA: Global Leader at International Safety Systems, Inc. 30+ years of conducting industrial hygiene assessment and training at 200+ pharma industries globally. Recepient of Yant Award from American Industrial Hygiene Association and Lifetime Achievement Award from Board for Global EHS Credentialling for promoting occupational hygiene globally.
  • Ankit Sharma, CIH, LFOH, Associate Director, International Safety Systems, Inc. Conducted industrial hygiene assessments and training at more than 50 pharma sites globally. Ankit and his team collected, interpreted and analysed more than 5000 surrogate and API exposure monitoring results. Provided potent compound control solutions and conducted practical training on potent compounds.
Type
Webinar
Date
5 Aug 2025 14:00–15:00 Amsterdam
Language
English
  • Water Use & Management
This resource was published on 12 June

PSCI Anti-Trust Statement EN CN

Organisational Information

The PSCI Anti-trust Statement in English and Chinese.

  • Updated 1 July 2025.
This bulletin was published on 3 June
The Pharmaceutical Supply Chain Initiative (PSCI) Marking a year of global impact

The Pharmaceutical Supply Chain Initiative (PSCI) Marking a year of global impact

  • Building on more than a decade of collaboration, the PSCI celebrates continued growth in membership, record audit sharing, and sector-wide engagement to strengthen responsible practices across the pharmaceutical and healthcare value chain.

  • The PSCI continues to serve as one voice for the pharmaceutical and healthcare industry, defining, instilling, and driving responsible value chain practices through collaboration, shared tools, and sector-wide engagement.

3 June 2025 –The Pharmaceutical Supply Chain Initiative (PSCI) has released its 2024 Annual Report, celebrating a year of strategic transformation and measurable progress in building responsible supply chains across the pharmaceutical and healthcare sectors.

Now representing over 70% of the industry by revenue, PSCI’s 81 member companies continue to collaborate through a shared commitment to the PSCI Principles for Responsible Supply Chain Management. In 2024, PSCI launched a new three-year strategy focused on deepening impact through its three core workstreams: Audit, Capability Building, and Projects.

Reflecting on the previous year, the 2024 PSCI Annual Report showcases the sector’s progress through the PSCI and its three modes of impact:

More Info…
This resource was published on 22 May

BSI Group

Audit Firm Information

Introduction deck for BSI Group

This resource was published on 19 May

EQMS Ingenuity Private Limited

Audit Firm Information

An introduction deck for EQMS Ingenuity Private Limited

This event was published on 6 May
Webinar: 阿斯利康无锡供应工厂节能减排实践分享 AstraZeneca Wuxi Site's Emission Reduction & Energy Saving Practices

Webinar: 阿斯利康无锡供应工厂节能减排实践分享 AstraZeneca Wuxi Site's Emission Reduction & Energy Saving Practices

Webinar | 5 Jun 2025 16:00–17:00 Beijing

本线上研讨会由PSCI中国小组筹备;会议语言为中文。
The webinar is sponsored by PSCI China regional team.
The presentation will be delivered in Mandarin.

研讨会话题
阿斯利康无锡供应工厂节能减排实践分享: 从战略到实践的可持续探索

注册/登录PSCI账户后即可报名,报名将于6月2日下午17:00点截止。参会指引邮件将于6月3日发出。

分享嘉宾
韦雁翔 - 阿斯利康无锡供应工厂 Associate Director Utility Management

线上研讨会话题简介
本次分享将介绍阿斯利康无锡供应工厂在节能减排方面的实际经验与探索过程

您将收获

  • 实践视角:不仅限于理念,深入了解医药供应链健谈过程中的现实挑战与应对方式
  • 战略对接:了解全球“零碳”目标如何转化为工厂的具体行动,平衡绿色转型与运营效率
  • 可借鉴的框架:涵盖技术改造、数字化转型和管理创新等多方面案例,多维度展现可参考的落地框架
  • 行业交流:与供应链及可持续发展领域从业者共同探讨行业低碳转型的趋势与实践路径

会议语言
本次研讨会会议语言为中文。

如您无法正常查看下方注册按钮,请您尝试更换浏览器打开此页面。

Topic
AstraZeneca Wuxi Site's Emission Reduction & Energy Saving Practices: From Strategy to Action

Overview
We will share Wuxi Site's best practices in energy conservation and emission reduction

You'll Gain

  • Firsthand examples of site-level energy conservation and emission reduction efforts
  • Data-informed approaches to energy efficiency and carbon management
  • Insights into cross-functional collaboration to support green transformation at the factory level

Please register your attendance before 2nd June. We'll send out meeting instructions & link on 3rd June.

Your Presenter
David Wei, Associate Director Utility Management at AstraZeneca Wuxi Site

Type
Webinar
Date
5 Jun 2025 16:00–17:00 Beijing
Language
Mandarin
This event is in the past